Pediatric Rheumatology

unofficial impact factor 1.74

Open Access Highly Access Email this article to a friend

Guilt by association - what is the true risk of malignancy in children treated with etanercept for JIA?

Randy Q Cron* and Timothy Beukelman

Pediatric Rheumatology 2010, 8:23 doi:10.1186/1546-0096-8-23

Fields marked * are required


Multiple email addresses should be separated with commas or semicolons.